Generic Product News (January 2018)

Pharmacy Times, January 2018 Oncology, Volume 84, Issue 1

Read about the new Generic Products featured in January.

CARVEDILOL PHOSPHATEMARKETED BY: Sun Pharmaceutical Industries Ltd

COMPARE TO: Coreg CR (GlaxoSmithKline)

INDICATION: The FDA has approved carvedilol phosphate, the generic version of Coreg CR. Carvedilol phosphate extended-releast tablets are indicated for the treatment of mild to severe chronic heart failure to increase survival and reduce hospitalization risk.

DOSAGE: Capsules: 10, 20, 40, and 80 mg

FOR MORE INFORMATION: sunpharma.com

NYSTATIN AND TRIAMCINOLONE ACETONIDE CREAMMARKETED BY: Perrigo

COMPARE TO: Mycolog II Cream (Apothecon)

INDICATION: Perrigo has launched nystatin and triamcinolone acetonide cream USP (100,000 units/g and 1 mg/g), an AB-rated generic version of Mycolog II Cream,which is indicated for the treatment of cutaneous candidiasis.

DOSAGE: Topical

FOR MORE INFORMATION: perrigo.com

HYDROMORPHONE HCLMARKETED BY: Perrigo

COMPARE TO: Exalgo (Mallinckrodt, Inc)

INDICATION: Perrigo has launched an AB-rated generic version of Exalgo (hydromorphone HCl) Extended-Release Tables (CII), which are indicated for the management of moderate to severe pain in opioid-tolerant patients requiring continuous opioid analgesia for an extended period of time.

DOSAGE: Tablets: 32 mg

FOR MORE INFORMATION: perrigo.com

HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETSMARKETED BY: Lupin Pharmaceuticals

COMPARE TO: Norco (Allergan)

INDICATION: Lupin Pharmaceuticals has launched its hydrocodone bitartrate and acetaminophen tablets USP. Norco is indicated for the relief of moderate to moderately severe pain.

DOSAGE: Tablets: 5 mg/325 mg, 7.5 mg/325 mg, and 10 mg/325 mg

FOR MORE INFORMATION: lupinpharmaceuticals.com